Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

Article Created on 13 Jul 2026 by GSK News Feed

Results support potential for dostarlimab to eliminate the need for chemotherapy, radiation and surgery in some patients

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement